COVID-19 Testing for COVID-19

Phase-Based Progress Estimates
COVID-19+6 More
COVID-19 Testing - Behavioral
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial is testing a new way to get people in a high-risk, underserved community to get COVID-19 tests.

Eligible Conditions
  • COVID-19
  • COVID-19 Pandemics

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Up to 6 months after end of study

31 weeks
COVID-19 Testing Uptake
Month 2
Needs Assessment
Month 6
Re-AIM Framework

Trial Safety

Trial Design

1 Treatment Group

COVID-19 Testing
1 of 1
Experimental Treatment

10000 Total Participants · 1 Treatment Group

Primary Treatment: COVID-19 Testing · No Placebo Group · N/A

COVID-19 Testing
Experimental Group · 1 Intervention: COVID-19 Testing · Intervention Types: Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Testing

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 6 months after end of study

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
379 Previous Clinical Trials
141,097 Total Patients Enrolled
6 Trials studying COVID-19
10,449 Patients Enrolled for COVID-19

Eligibility Criteria

Age Any Age · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: October 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Met criteria100.0%